Metformin-Therapie bei PCO-Syndrom - Positive Vierjahresbilanz des oralen Antidiabetikums
The Polycystic ovary syndrome (PCOS) is the most frequent endocrinal disease of women in child-bearing age. PCOS represents a high risk for infertility, metabolic and cardiovascular diseases. This article analyses the outcomes after four years of PCOS-treatment with Metformin, an orally administered medication. We describe under which circumstances Metformin treatment is useful.